Thoracic (Lung/chest)
NRG – S1914 at https://clinicaltrials.gov/study/NCT04214262
A randomized, phase III trial of induction/consolidation atelzolizumab (NSC #783608) + SBRT vs SBRT alone in high-risk, early-stage non-small-cell lung cancer (NSCLC)
Cancer Type: NSCLC, Stage I-IIA, high-risk
Principal Investigator: Dr. Debra Brandt
Please contact Clinical Trials Office for more details: 561-263-5791
-
Jupiter Medical Center
We want to help you! If you have questions about our services and what we can offer you and your loved ones, please reach out.